![](/img/cover-not-exists.png)
Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
Whaley, Jean, Tirmenstein,, Reilly,, Poucher,, Saye,, Parikh,, List,Language:
english
Journal:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
DOI:
10.2147/DMSO.S22503
Date:
July, 2012
File:
PDF, 2.12 MB
english, 2012